Arthur Benvenuto Arthur Benvenuto Arthur Benvenuto Arthur Benvenuto Arthur Benvenuto Arthur Benvenuto Arthur Benvenuto Arthur Benvenuto Arthur Benvenuto Arthur Benvenuto Arthur Benvenuto
Welcome to Micell Technologies, Inc., a privately-held, early-stage biomedical company dedicated to advancing combination product therapies in the cardiovascular, orthopedic, and drug-delivery areas.

Our Supercritical Fluid Technology consists of patented processes and methods for surface modifications of medical devices with specific focus on improvements to current polymer based drug-eluting technologies.  Included in our technology platform are exclusively licensed patents from Battelle.  The patented technology was developed at Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle.

Our development team has significant expertise in supercritical fluid technology and has developed semiconductor and industrial applications.


Watch Video
April 18, 2007
Micell Technologies Presents Data on Novel Drug-Eluting Stents

December 8, 2006
Micell Technologies Announces Appointment of New Chief Financial Officer

Home Corporate Overview Technology Overview Biomedical Applications Intellectual Property Contact Info